Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My guess as to one of the problems is international sales. Third quarter only $9,000 of nearly $2 million had been realized. Back out those sales, as I have pointed out in other posts, 2007 sales are down to around $8 million versus $16 million two years earlier.
He knows.
Have been wondering if the Wall Street Transcript will run another feature of VODG???
In the past, WST has done some articles of VODG in April. The articles have created some nice trading moves, but nothing sustainable because there wasn't anything to sustain it.
Let me think, something important may happen in April. Oh yea, now, wouldn't THAT be sweet?
A HARBINGER OF REALLY BAD NEWS AND AN UNFOLDING SCAM RIGHT BEFORE OUR EYES???????????
MITD filed a late notification for their 10K on March 31. Not unusual in and of itself but what was astonishing was the contact person named was a Steven W. Schuster. He is the Company's attorney and note he is co-chair of McLaughlin & Stern's corporate and securities department.
"Steven W. Schuster, Esq.
Mr. Schuster became a member of the Board of Directors of MIT in 2006. Mr. Schuster has been engaged in the practice of corporate law for over 25 years and is co-chair of McLaughlin & Stern LLP’s corporate and securities department, where he has worked since 1995. Since 1997, he has served as a member of the Board of Directors of Tower Group, Inc., a publicly traded holding company whose subsidiaries are providers of insurance. Mr. Schuster received his B.A. from Harvard University in 1976 and his J.D. from New York University in 1980."
HOW CAN THIS BE ANYTHING OTHER THAN A HARBINGER OF REALLY BAD NEWS?
Yes what you restated is correct about the patent(s). I have signed confidentiality agreements that would be violated if I answered you question.
Would be interested in comments on my conclusions:
1). That VODG is likely to be a win/win situation;
2). Comparison to FORD.
3). Has the scotch finally pickled my brain or am I possibly onto something?
Thanks for the clarification. Don't know about the investors he is referring to precisely. My comment had to do with the large number of smaller shareholders that sum to a meaningful number. Many of these shareholders date back to the mid 1990's. If that was what Dr. Musick was referring to then I have a better grasp of that situation.
Many of those shareholders are not to be found. There was a couple of attempts to get in touch with them. One time was around 2002-04 when VODG hired a West Coast PR firm. They attempted contact via the shareholder list with marginal success.
Guess that's what makes markets. Everybody is entitled to an opinion. It seems silly to ask for my opinion and then disagree with one thing versus looking at the totality of what I said.
You may well be right, but with all respect, my experience covers way, way more than a few phone conversations. In addition, I have detailed and intimate knowledge of the FSH business when Roger was at VODG.
My intention is not to get into a contest and this type of response is why I tend not to share my opinions.
Why VODG could be a WIN/WIN.
After much work and thought I have come to the conclusion that VODG just could be a win/win situation.
It would take too long to cover this subject. Read my post on 10 reasons why and some of the other outstanding DD on this board.
I have never questioned the grants, etc. and the platform potential that exists with VODG. A tiny company that could find itself in a multi billion dollar marketplace. My consistent concern has been whether or not the good doctor and create a business model that works. My conclusion, right or wrong, is, based on events to date, he doesn't have to be. If the chemistry/biology is right (which I am 99% confident in) events have transpired that will cause VODG to become successful even if the brilliant doctor isn't a businessman.
I have hesitated to say all these things because I am not pumping this stock and frankly don't care if it is successful over the foreseeable future. I would rather see the stock rise orderly. The move from 40 cents to 4 dollars was pretty fast and at a time when the OTC market was in tulip bulb land. However, the future has never been clearer or better defined as futures can be that is.
A tremendous amount of things have to happen, but the odds look awfully good to me and I think it could be great fun to be in this stock and who knows, maybe my kids kids will get a piece of the action, much like my tiny piece of P&G.
I consider myself to be very fortunate - aren't too many things that could be more fun than this.
Could VODG be the 21st Century FORD?
Think about it. A company comes along that can mass produce a new contraption called an automobile. Whats wrong with buggies and buggy whips?
It might be and then again it might not be, but I would be willing to wager a reasonable size of money that wouldn't impact my day to day existence that VODG just could be that a modern day Ford Motor Company. First to mass produce cars, first to mass produce the next multi-generational development in the Pharmaceutical Industry.
Luck favors a prepared mind.
My perspective as the clock ticks to 4/15.
Scenario #1 - VODG doesn't meet deadline.
Stock probably drops in price. I would be plenty happy and probably blow my cover and file a D.
Scenario #2 - VODG meets deadline.
Sweet!
Reasoning to follow in another post. But I want to add the following disclaimer.
As I have stated I have been investing for years. In fact, I used to appear in the WSJ 4-6 times a year and was once called a small cap guru.
I maybe good, but I have never lost sight of how important luck really is in this game.
That said, I have and can be wrong.
Now with that I will provide you with my personal opinion and I won't charge you anything
If I wanted to get real blue sky on this I would tell you there is a chance that:
VODG is a possible example of a 21st century FORD.
Fact is I don't need to come even close to that to see this investment do exceptional things.
Let's just take a hypothetical (yea, right) case. Say 600,000 shares at an average price of 10. Someone may just be willing to bet all of 60,000 to make what??? Well you do the math.
VODG is one of the few BB stocks that nearly everyone ligit investor is this fantasy land is looking for.
My perspective dates back to 1998.
1). There aren't that many shares "free trading".
2). David sights stockholders, and what he says is true. My perspective is from having waded through the actual list of shareholders several times, yea all 1,900+.
3). IMO, many shareholders date back to a time that I personally feel they no longer are active, involved and in some (maybe quite a few) don't know or care. Liquidity in the stock is made up of short term MM's and the few longer term investors and/or traders.
4). Therefore, stock trades on low volume until levels are reached that attract "longer" term shareholders. At times I have found running the stock 10-15 cents and then backing off to be an effective way to buy some size. I don't think that will work at this moment in time however.
5). I am a value investor who believes charts can be of help. In this case they can be and are very revealing. David will remember me passing along stock levels like 30c, the 40-45 range, etc. This stock does have a dependable chart and prior events that drove the stock to these important levels.
6). VODG can be hugely frustrating over the short term. If one is a short term trader then I would advise a small position. If one is a long term trader or investor (as I am) then building a position takes on an entirely different perspective and different methods work in different markets.
Hope this helps, would be happy to address specifics if anybody wants. That said, I don't have a corner on this, I have been pretty successful for over 30+ years however.
I believe ever stock is different. Here is a real life example on VODG. I mentioned it to a very successful doctor. He tried to buy some and had trouble. I asked him how much and he said 15,000 shares. Meaningful, but not significant to me in this situation. I sold him 15,000 shares in a private transaction for 19 and turned around on Friday and purchased 15,000 at 25. Why? Because I think the difference between 19 and 25 is insignificant.
Thank you for asking. Posts to follow.
Thank you!
davidam - would you be so kind as to take your private business and, well, geee ... make it private and don't waste my time with your personal stuff?
Wonder what you all think?
If you want, do some research on the new equity participants. Given their background, experience, etc. what happens if:
1). Company meets hurdles?
2). Company does not meet hurdles?
3). Could this be a win/win?
If you don't mind, add your comments as to why, etc.
Don't bother replying if you don't do the background work.
To follow your thinking, here be my 2 pennies, after all these are penny stocks!
Dr. Musick plays it close to the vest. That's why I have said what he doesn't say can be more important than what he does say. Would suggest when you talk with him to have questions written out, then construct a strategy of how to ask them.
He has lugged VODG to long to add overhead without income period.
He gave you the impression something might be in the works. Could happen, but don't think shareholders need to see it to make the stock work extremely well.
Highly unlikely that he would go along with BEING acquired. Isn't in his nature and I know he turned down a bid for the Company several years ago in the $2 range.
I just had a brilliant glimpse of the obvious.
Years of experience have taught me it is what management doesn't say that can be more important than what they do say. I have good reason to believe Dr. Musick considered, but is not planning to hire a PR or IR firm.
The reason WHY could be revealing...
Because the stock won't need it until some point down the road. Yes, VODG will need more funding, in time, but until then the stock could/will be meaningfully higher if/when the hurtles are met.
I am pretty confident that the one thing this isn't is a scam.
1). The only thing I know that is bothersome is the guarantee of funds backed by FSH patent(s). That happened quite awhile ago, spoke with Dr. Musick about it and don't think it is a problem in the least little bit.
2). Furthermore, look into the background of the new equity investors. The one gentleman has extensive and exceptional experience in small cap stocks.
3). Interesting as well, he is an oil man from the heartland. Mr. Lloyd Hansen, a long time 10% owner of VODG, according to filings, also made his money in oil, in the heartland. A coincidence? Emmm, let me guess ...
Procter & Gamble
Very happy to see your good work and that you are becoming a believer. Now let me restate and hopefully add to your excellent work, as I have come to understand it.
1). Platform products is absolutely correct.
2). The "methodology" of the patent of introducing DNA is unique & patented by VODG. Cell lines in vitro have not turned cancerous.
3). The "methodology" is that the cells are not rejected by the recipient.
IMO, the real question has not been the science, or whatever you want to call it. The good Dr. is brilliant as the above testifies. The real question - can he turn VODG in to a business?
I think the answer is a resounding YES! Others are a little more skeptical than I am. As I have said, I know Jim well, Eric as well, even have had dinner with him and his wife Phylis. I also recognize that doesn't mean I am or will be right. Over the years I have learned not to confuse intelligence with luck.
What better place to have an investment in today's market than a Company in 5 years or so we all could look back and say "I was there". Maybe like my great grandfather, who invested in a small Southern Ohio company at the time. Care to guess what company?
FYI - The number 3 guy at Eli Lilly was an adviser to the Company back when it made its big move. Might still be a shareholder.
Question.
What is Eli Lilly known for?
TEN REASONS WHY VODG IS WHAT EVERY BB INVESTOR IS LOOKING FOR.
1). A company who has struggled and is emerging as a producer of products that have significant demand.
2). A company whose management is honest and walks the walk. Meaning they have proven to be focused on maximizing shareholder value. If shareholders get rich, so will management.
3). A company who has reached production stages and is not burdened with debt.
4). Proprietary products.
5). Potential Platform drug products.
6). Patents and patent(s) pending that are unique.
7). A company for whatever reason is under the radar, has not been pumped and dumped by LeBed or other Master Pimp artists.
8). Very sophisticated and proven equity investors who were willing to pay over a 100% premium to buy a significant stake, which is still below current market prices!
9). A company whose products will change peoples lives.
10). A company whose products are not economically sensitive.
Ya, relax and enjoy the ride if you are long the stock. And who knows, maybe we will look back in 5 years and see that we were at the beginning of a historical event. On the otherhand, maybe not, after all, that is what this game is all about.
Disclaimer. I own slightly less than 5% of the stock and I know people who own nearly 20%. While I can't specifically speak for them, I can say, "I ain't selling".
$4.75, I was there. So was Dr. Musick and Roger Hurst. Both sold stock in the $4 range. Won't do it this time, IMHO.
Right, and I believe you. Please provide me with the number for Vidalia? Is still open?
MIT Holding and subs are named in the suit.
Who did you talk to at the company?
Your post doesn't make sense.
Are you saying the suit doesn't exist or that it isn't against MIT holdings or just what?
Please clarify, since your prior posts say you know people at the company, it would be helpful.
Otherwise, this will be strike three against MIT for me and any potential investment.
I KNOW they will.
Why do I know?
I have seen and read company patents (publicly obtained) and have had people from top Pharm companies review. The patent for cell immortalization is unique to VODG. It's methodology does not result in cancerous growths - period.
PLEASE, don't turn this into a typical "gushy" board. Look at the history here - Dr. Musick is not interested in a pump and dump, in fact he hasn't (and won't) hire a PR firm. This stock should be an incredible investment, not a one, two or even six month wonder.
Relax, enjoy the ride, and in time we will see new highs. Just let it happen naturally and keep focused on the fundamentals.
$3 million plus??? Sounds major.
JUST an employee???
Ahhh, there are three suits, 3 people, all employees???
Just looking for the facts.
BAD NEWS BRO!
LOOKIE WHAT I FOUND:
3 SEXUAL ABUSE CASES - FILED 11/14/2007
Each case $1 million plus. Funny how bad news goes unreported to shareholders ....
CASE #1: STCV0704614 http://www.chathamcounty.org/jims/docket...
CASE #2: STCV0704615 http://www.chathamcounty.org/jims/docket...
CASE #3: STCV0704616 http://www.chathamcounty.org/jims/docket...